 | • レポートコード：MRC23Q36646 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の注射用アザシチジン市場について調査・分析し、世界の注射用アザシチジン市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（先発医薬品、ジェネリック医薬品）、用途別セグメント分析（病院、診療所、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Celgene、Meitheal Pharmaceuticals、Lupin Limited、Cipla、TEVA、Viatris、Dr. Reddy's Laboratories、Amneal Pharmaceuticals、Natco Pharma、Accord Healthcare、Shilpa Medicare、Chia Tai Tianqing Pharmaceutical、Jiangsu Hansoh Pharmaceutical、Sichuan Huiyu Pharmaceuticalなどが含まれています。世界の注射用アザシチジン市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、注射用アザシチジン市場規模を推定する際に考慮しました。本レポートは、注射用アザシチジンの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、注射用アザシチジンに関するビジネス上の意思決定に役立てることを目的としています。 ・注射用アザシチジン市場の概要 - 製品の定義 - 注射用アザシチジンのタイプ別セグメント - 世界の注射用アザシチジン市場規模：タイプ別分析（先発医薬品、ジェネリック医薬品） - 注射用アザシチジンの用途別セグメント - 世界の注射用アザシチジン市場規模：用途別分析（病院、診療所、その他） - 世界の注射用アザシチジン市場規模予測（2018年-2029年） - 注射用アザシチジンの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 注射用アザシチジン市場の競争状況およびトレンド ・注射用アザシチジンの地域別市場規模 - 北米の注射用アザシチジン市場規模（2018年-2029年） - アメリカの注射用アザシチジン市場規模（2018年-2029年） - ヨーロッパの注射用アザシチジン市場規模（2018年-2029年） - アジア太平洋の注射用アザシチジン市場規模（2018年-2029年） - 中国の注射用アザシチジン市場規模（2018年-2029年） - 日本の注射用アザシチジン市場規模（2018年-2029年） - 韓国の注射用アザシチジン市場規模（2018年-2029年） - インドの注射用アザシチジン市場規模（2018年-2029年） - オーストラリアの注射用アザシチジン市場規模（2018年-2029年） - 中南米の注射用アザシチジン市場規模（2018年-2029年） - 中東・アフリカの注射用アザシチジン市場規模（2018年-2029年） ・タイプ別セグメント：先発医薬品、ジェネリック医薬品 - 世界の注射用アザシチジンのタイプ別販売量（2018年-2023年） - 世界の注射用アザシチジンのタイプ別売上（2018年-2023年） - 世界の注射用アザシチジンのタイプ別価格 ・用途別セグメント：病院、診療所、その他 - 世界の注射用アザシチジンの用途別販売量（2018年-2023年） - 世界の注射用アザシチジンの用途別売上（2018年-2023年） - 世界の注射用アザシチジンの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Celgene、Meitheal Pharmaceuticals、Lupin Limited、Cipla、TEVA、Viatris、Dr. Reddy's Laboratories、Amneal Pharmaceuticals、Natco Pharma、Accord Healthcare、Shilpa Medicare、Chia Tai Tianqing Pharmaceutical、Jiangsu Hansoh Pharmaceutical、Sichuan Huiyu Pharmaceutical ・産業チェーンと販売チャネルの分析 - 注射用アザシチジン産業チェーン分析 - 注射用アザシチジンの主要原材料 - 注射用アザシチジンの販売チャネル - 注射用アザシチジンのディストリビューター - 注射用アザシチジンの主要顧客 ・注射用アザシチジン市場ダイナミクス - 注射用アザシチジンの業界動向 - 注射用アザシチジン市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Azacitidine for Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Azacitidine for Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Azacitidine for Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Azacitidine for Injection include Celgene, Meitheal Pharmaceuticals, Lupin Limited, Cipla, TEVA, Viatris, Dr. Reddy’s Laboratories, Amneal Pharmaceuticals and Natco Pharma, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Azacitidine for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Azacitidine for Injection.
The Azacitidine for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Azacitidine for Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Azacitidine for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Celgene
Meitheal Pharmaceuticals
Lupin Limited
Cipla
TEVA
Viatris
Dr. Reddy’s Laboratories
Amneal Pharmaceuticals
Natco Pharma
Accord Healthcare
Shilpa Medicare
Chia Tai Tianqing Pharmaceutical
Jiangsu Hansoh Pharmaceutical
Sichuan Huiyu Pharmaceutical
Segment by Type
Original Drug
Generic Drug
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Azacitidine for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Azacitidine for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Azacitidine for Injection Market Overview
1.1 Product Overview and Scope of Azacitidine for Injection
1.2 Azacitidine for Injection Segment by Type
1.2.1 Global Azacitidine for Injection Market Value Comparison by Type (2023-2029)
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Azacitidine for Injection Segment by Application
1.3.1 Global Azacitidine for Injection Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Azacitidine for Injection Market Size Estimates and Forecasts
1.4.1 Global Azacitidine for Injection Revenue 2018-2029
1.4.2 Global Azacitidine for Injection Sales 2018-2029
1.4.3 Global Azacitidine for Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Azacitidine for Injection Market Competition by Manufacturers
2.1 Global Azacitidine for Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Azacitidine for Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Azacitidine for Injection Average Price by Manufacturers (2018-2023)
2.4 Global Azacitidine for Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Azacitidine for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Azacitidine for Injection, Product Type & Application
2.7 Azacitidine for Injection Market Competitive Situation and Trends
2.7.1 Azacitidine for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Azacitidine for Injection Players Market Share by Revenue
2.7.3 Global Azacitidine for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Azacitidine for Injection Retrospective Market Scenario by Region
3.1 Global Azacitidine for Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Azacitidine for Injection Global Azacitidine for Injection Sales by Region: 2018-2029
3.2.1 Global Azacitidine for Injection Sales by Region: 2018-2023
3.2.2 Global Azacitidine for Injection Sales by Region: 2024-2029
3.3 Global Azacitidine for Injection Global Azacitidine for Injection Revenue by Region: 2018-2029
3.3.1 Global Azacitidine for Injection Revenue by Region: 2018-2023
3.3.2 Global Azacitidine for Injection Revenue by Region: 2024-2029
3.4 North America Azacitidine for Injection Market Facts & Figures by Country
3.4.1 North America Azacitidine for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Azacitidine for Injection Sales by Country (2018-2029)
3.4.3 North America Azacitidine for Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Azacitidine for Injection Market Facts & Figures by Country
3.5.1 Europe Azacitidine for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Azacitidine for Injection Sales by Country (2018-2029)
3.5.3 Europe Azacitidine for Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Azacitidine for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Azacitidine for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Azacitidine for Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Azacitidine for Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Azacitidine for Injection Market Facts & Figures by Country
3.7.1 Latin America Azacitidine for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Azacitidine for Injection Sales by Country (2018-2029)
3.7.3 Latin America Azacitidine for Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Azacitidine for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Azacitidine for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Azacitidine for Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Azacitidine for Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Azacitidine for Injection Sales by Type (2018-2029)
4.1.1 Global Azacitidine for Injection Sales by Type (2018-2023)
4.1.2 Global Azacitidine for Injection Sales by Type (2024-2029)
4.1.3 Global Azacitidine for Injection Sales Market Share by Type (2018-2029)
4.2 Global Azacitidine for Injection Revenue by Type (2018-2029)
4.2.1 Global Azacitidine for Injection Revenue by Type (2018-2023)
4.2.2 Global Azacitidine for Injection Revenue by Type (2024-2029)
4.2.3 Global Azacitidine for Injection Revenue Market Share by Type (2018-2029)
4.3 Global Azacitidine for Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Azacitidine for Injection Sales by Application (2018-2029)
5.1.1 Global Azacitidine for Injection Sales by Application (2018-2023)
5.1.2 Global Azacitidine for Injection Sales by Application (2024-2029)
5.1.3 Global Azacitidine for Injection Sales Market Share by Application (2018-2029)
5.2 Global Azacitidine for Injection Revenue by Application (2018-2029)
5.2.1 Global Azacitidine for Injection Revenue by Application (2018-2023)
5.2.2 Global Azacitidine for Injection Revenue by Application (2024-2029)
5.2.3 Global Azacitidine for Injection Revenue Market Share by Application (2018-2029)
5.3 Global Azacitidine for Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Celgene
6.1.1 Celgene Corporation Information
6.1.2 Celgene Description and Business Overview
6.1.3 Celgene Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Celgene Azacitidine for Injection Product Portfolio
6.1.5 Celgene Recent Developments/Updates
6.2 Meitheal Pharmaceuticals
6.2.1 Meitheal Pharmaceuticals Corporation Information
6.2.2 Meitheal Pharmaceuticals Description and Business Overview
6.2.3 Meitheal Pharmaceuticals Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Meitheal Pharmaceuticals Azacitidine for Injection Product Portfolio
6.2.5 Meitheal Pharmaceuticals Recent Developments/Updates
6.3 Lupin Limited
6.3.1 Lupin Limited Corporation Information
6.3.2 Lupin Limited Description and Business Overview
6.3.3 Lupin Limited Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Lupin Limited Azacitidine for Injection Product Portfolio
6.3.5 Lupin Limited Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cipla Azacitidine for Injection Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 TEVA
6.5.1 TEVA Corporation Information
6.5.2 TEVA Description and Business Overview
6.5.3 TEVA Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 TEVA Azacitidine for Injection Product Portfolio
6.5.5 TEVA Recent Developments/Updates
6.6 Viatris
6.6.1 Viatris Corporation Information
6.6.2 Viatris Description and Business Overview
6.6.3 Viatris Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Viatris Azacitidine for Injection Product Portfolio
6.6.5 Viatris Recent Developments/Updates
6.7 Dr. Reddy’s Laboratories
6.6.1 Dr. Reddy’s Laboratories Corporation Information
6.6.2 Dr. Reddy’s Laboratories Description and Business Overview
6.6.3 Dr. Reddy’s Laboratories Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dr. Reddy’s Laboratories Azacitidine for Injection Product Portfolio
6.7.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.8 Amneal Pharmaceuticals
6.8.1 Amneal Pharmaceuticals Corporation Information
6.8.2 Amneal Pharmaceuticals Description and Business Overview
6.8.3 Amneal Pharmaceuticals Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Amneal Pharmaceuticals Azacitidine for Injection Product Portfolio
6.8.5 Amneal Pharmaceuticals Recent Developments/Updates
6.9 Natco Pharma
6.9.1 Natco Pharma Corporation Information
6.9.2 Natco Pharma Description and Business Overview
6.9.3 Natco Pharma Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Natco Pharma Azacitidine for Injection Product Portfolio
6.9.5 Natco Pharma Recent Developments/Updates
6.10 Accord Healthcare
6.10.1 Accord Healthcare Corporation Information
6.10.2 Accord Healthcare Description and Business Overview
6.10.3 Accord Healthcare Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Accord Healthcare Azacitidine for Injection Product Portfolio
6.10.5 Accord Healthcare Recent Developments/Updates
6.11 Shilpa Medicare
6.11.1 Shilpa Medicare Corporation Information
6.11.2 Shilpa Medicare Azacitidine for Injection Description and Business Overview
6.11.3 Shilpa Medicare Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Shilpa Medicare Azacitidine for Injection Product Portfolio
6.11.5 Shilpa Medicare Recent Developments/Updates
6.12 Chia Tai Tianqing Pharmaceutical
6.12.1 Chia Tai Tianqing Pharmaceutical Corporation Information
6.12.2 Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Description and Business Overview
6.12.3 Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Product Portfolio
6.12.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
6.13 Jiangsu Hansoh Pharmaceutical
6.13.1 Jiangsu Hansoh Pharmaceutical Corporation Information
6.13.2 Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Description and Business Overview
6.13.3 Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Product Portfolio
6.13.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
6.14 Sichuan Huiyu Pharmaceutical
6.14.1 Sichuan Huiyu Pharmaceutical Corporation Information
6.14.2 Sichuan Huiyu Pharmaceutical Azacitidine for Injection Description and Business Overview
6.14.3 Sichuan Huiyu Pharmaceutical Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Sichuan Huiyu Pharmaceutical Azacitidine for Injection Product Portfolio
6.14.5 Sichuan Huiyu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Azacitidine for Injection Industry Chain Analysis
7.2 Azacitidine for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Azacitidine for Injection Production Mode & Process
7.4 Azacitidine for Injection Sales and Marketing
7.4.1 Azacitidine for Injection Sales Channels
7.4.2 Azacitidine for Injection Distributors
7.5 Azacitidine for Injection Customers
8 Azacitidine for Injection Market Dynamics
8.1 Azacitidine for Injection Industry Trends
8.2 Azacitidine for Injection Market Drivers
8.3 Azacitidine for Injection Market Challenges
8.4 Azacitidine for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
